1 Ferlay, J, Shin, HR, Bray, F, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127, 2893–2917.
2 Rudd, RM, Gower, NH, Spiro, SG, et al. (2005) Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group. J Clin Oncol 23, 142–153.
3 Martoni, A, Marino, A, Sperandi, F, et al. (2005) Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer. Eur J Cancer 41, 81–92.
4 Lam, TK, Gallicchio, L, Lindsley, K, et al. (2009) Cruciferous vegetable consumption and lung cancer risk: a systematic review. Cancer Epidemiol Biomarkers Prev 18, 184–195.
5 Wu, X, Zhou, QH & Xu, K (2009) Are isothiocyanates potential anti-cancer drugs? Acta Pharmacol Sin 30, 501–512.
6 Xu, K & Thornalley, PJ (2001) Signal transduction activated by the cancer chemopreventive isothiocyanates: cleavage of BID protein, tyrosine phosphorylation and activation of JNK. Br J Cancer 84, 670–673.
7 Xu, K & Thornalley, PJ (2000) Studies on the mechanism of the inhibition of human leukaemia cell growth by dietary isothiocyanates and their cysteine adducts in vitro. Biochem Pharmacol 60, 221–231.
8 Gong, A, He, M, Krishna Vanaja, D, et al. (2009) Phenethyl isothiocyanate inhibits STAT3 activation in prostate cancer cells. Mol Nutr Food Res 53, 878–886.
9 Kang, L, Ding, L & Wang, ZY (2009) Isothiocyanates repress estrogen receptor alpha expression in breast cancer cells. Oncol Rep 21, 185–192.
10 Mi, L, Gan, N, Cheema, A, et al. (2009) Cancer preventive isothiocyanates induce selective degradation of cellular alpha- and beta-tubulins by proteasomes. J Biol Chem 284, 17039–17051.
11 Mukherjee, S, Dey, S, Bhattacharya, RK, et al. (2009) Isothiocyanates sensitize the effect of chemotherapeutic drugs via modulation of protein kinase C and telomerase in cervical cancer cells. Mol Cell Biochem 330, 9–22.
12 Prawan, A, Saw, CL, Khor, TO, et al. (2009) Anti-NF-kappaB and anti-inflammatory activities of synthetic isothiocyanates: effect of chemical structures and cellular signaling. Chem Biol Interact 179, 202–211.
13 Xiao, D & Singh, SV (2007) Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo. Cancer Res 67, 2239–2246.
14 Thejass, P & Kuttan, G (2007) Inhibition of endothelial cell differentiation and proinflammatory cytokine production during angiogenesis by allyl isothiocyanate and phenyl isothiocyanate. Integr Cancer Ther 6, 389–399.
15 Thejass, P & Kuttan, G (2007) Allyl isothiocyanate (AITC) and phenyl isothiocyanate (PITC) inhibit tumour-specific angiogenesis by downregulating nitric oxide (NO) and tumour necrosis factor-alpha (TNF-alpha) production. Nitric Oxide 16, 247–257.
16 Hwang, ES & Lee, HJ (2008) Benzyl isothiocyanate inhibits metalloproteinase-2/-9 expression by suppressing the mitogen-activated protein kinase in SK-Hep1 human hepatoma cells. Food Chem Toxicol 46, 2358–2364.
17 Lai, KC, Huang, AC, Hsu, SC, et al. (2010) Benzyl isothiocyanate (BITC) inhibits migration and invasion of human colon cancer HT29 cells by inhibiting matrix metalloproteinase-2/-9 and urokinase plasminogen (uPA) through PKC and MAPK signaling pathway. J Agric Food Chem 58, 2935–2942.
18 Hunakova, L, Sedlakova, O, Cholujova, D, et al. (2009) Modulation of markers associated with aggressive phenotype in MDA-MB-231 breast carcinoma cells by sulforaphane. Neoplasma 56, 548–556.
19 Wu, X, Zhu, Y, Yan, H, et al. (2010) Isothiocyanates induce oxidative stress and suppress the metastasis potential of human non-small cell lung cancer cells. BMC Cancer 10, 269.
20 Zhou, Q, Wang, Y, Che, G, et al. (2003) Establishment and their biological characteristics of clonal cell subpopulations (NL9980 and L9981) from a human lung large cell carcinoma cell line (WCQH29801). Chin J Lung Canc 6, 464–468.
21 Xu, K, Guidez, F, Glasow, A, et al. (2005) Benzodithiophenes potentiate differentiation of acute promyelocytic leukemia cells by lowering the threshold for ligand-mediated corepressor/coactivator exchange with retinoic acid receptor alpha and enhancing changes in all-trans-retinoic acid-regulated gene expression. Cancer Res 65, 7856–7865.
22 Gupta, GP & Massague, J (2006) Cancer metastasis: building a framework. Cell 127, 679–695.
23 Yu, R, Mandlekar, S, Harvey, KJ, et al. (1998) Chemopreventive isothiocyanates induce apoptosis and caspase-3-like protease activity. Cancer Res 58, 402–408.
24 Hu, R, Kim, BR, Chen, C, et al. (2003) The roles of JNK and apoptotic signaling pathways in PEITC-mediated responses in human HT-29 colon adenocarcinoma cells. Carcinogenesis 24, 1361–1367.
25 Xiao, D, Srivastava, SK, Lew, KL, et al. (2003) Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits proliferation of human prostate cancer cells by causing G2/M arrest and inducing apoptosis. Carcinogenesis 24, 891–897.
26 Miyoshi, N, Uchida, K, Osawa, T, et al. (2004) A link between benzyl isothiocyanate-induced cell cycle arrest and apoptosis: involvement of mitogen-activated protein kinases in the Bcl-2 phosphorylation. Cancer Res 64, 2134–2142.
27 Miyoshi, N, Uchida, K, Osawa, T, et al. (2004) Benzyl isothiocyanate modifies expression of the G2/M arrest-related genes. Biofactors 21, 23–26.
28 Inamdar, GS, Madhunapantula, SV & Robertson, GP (2010) Targeting the MAPK pathway in melanoma: why some approaches succeed and other fail. Biochem Pharmacol 80, 624–637.
29 Satyan, KS, Swamy, N, Dizon, DS, et al. (2006) Phenethyl isothiocyanate (PEITC) inhibits growth of ovarian cancer cells by inducing apoptosis: role of caspase and MAPK activation. Gynecol Oncol 103, 261–270.
30 Shaulian, E & Karin, M (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4, E131–E136.
31 Oya, M, Takayanagi, A, Horiguchi, A, et al. (2003) Increased nuclear factor-kappa B activation is related to the tumor development of renal cell carcinoma. Carcinogenesis 24, 377–384.
32 Xu, C, Shen, G, Yuan, X, et al. (2006) ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells. Carcinogenesis 27, 437–445.
33 Yao, S, Zhang, Y & Li, J (2006) c-jun/AP-1 activation does not affect the antiproliferative activity of phenethyl isothiocyanate, a cruciferous vegetable-derived cancer chemopreventive agent. Mol Carcinog 45, 605–612.
34 Jeong, WS, Kim, IW, Hu, R, et al. (2004) Modulation of AP-1 by natural chemopreventive compounds in human colon HT-29 cancer cell line. Pharm Res 21, 649–660.
35 Shen, G, Xu, C, Chen, C, et al. (2006) p53-independent G1 cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1. Cancer Chemother Pharmacol 57, 317–327.
36 Batra, S, Sahu, RP, Kandala, PK, et al. (2010) Benzyl isothiocyanate-mediated inhibition of histone deacetylase leads to NF-kappaB turnoff in human pancreatic carcinoma cells. Mol Cancer Ther 9, 1596–1608.
37 Sun, Y & Rigas, B (2008) The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents. Cancer Res 68, 8269–8277.
38 Trachootham, D, Zhang, H, Zhang, W, et al. (2008) Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism. Blood 112, 1912–1922.
39 Xiao, D, Powolny, AA & Singh, SV (2008) Benzyl isothiocyanate targets mitochondrial respiratory chain to trigger reactive oxygen species-dependent apoptosis in human breast cancer cells. J Biol Chem 283, 30151–30163.
40 Sahu, RP, Zhang, R, Batra, S, et al. (2009) Benzyl isothiocyanate-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of MAPK in human pancreatic cancer cells. Carcinogenesis 30, 1744–1753.
41 Faustman, D & Davis, M (2010) TNF receptor 2 pathway: drug target for autoimmune diseases. Nat Rev Drug Discov 9, 482–493.
42 Sheedy, FJ, Palsson-McDermott, E, Hennessy, EJ, et al. (2010) Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 11, 141–147.
43 King, FW, Fong, S, Griffin, C, et al. (2009) Timosaponin AIII is preferentially cytotoxic to tumor cells through inhibition of mTOR and induction of ER stress. PLoS One 4, e7283.
44 Satomi, Y & Nishino, H (2009) Implication of mitogen-activated protein kinase in the induction of G1 cell cycle arrest and gadd45 expression by the carotenoid fucoxanthin in human cancer cells. Biochim Biophys Acta 1790, 260–266.
45 Le, XF, Arachchige-Don, AS, Mao, W, et al. (2007) Roles of human epidermal growth factor receptor 2, c-jun NH2-terminal kinase, phosphoinositide 3-kinase, and p70 S6 kinase pathways in regulation of cyclin G2 expression in human breast cancer cells. Mol Cancer Ther 6, 2843–2857.